Lu, C.-Y.; Hsiao, C.-Y.; Peng, P.-J.; Huang, S.-C.; Chuang, M.-R.; Su, H.-J.; Huang, K.-W.
DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma. Cancers 2023, 15, 4465.
https://doi.org/10.3390/cancers15184465
AMA Style
Lu C-Y, Hsiao C-Y, Peng P-J, Huang S-C, Chuang M-R, Su H-J, Huang K-W.
DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma. Cancers. 2023; 15(18):4465.
https://doi.org/10.3390/cancers15184465
Chicago/Turabian Style
Lu, Chang-Yi, Chih-Yang Hsiao, Pey-Jey Peng, Shao-Chang Huang, Meng-Rong Chuang, Hung-Ju Su, and Kai-Wen Huang.
2023. "DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma" Cancers 15, no. 18: 4465.
https://doi.org/10.3390/cancers15184465
APA Style
Lu, C.-Y., Hsiao, C.-Y., Peng, P.-J., Huang, S.-C., Chuang, M.-R., Su, H.-J., & Huang, K.-W.
(2023). DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma. Cancers, 15(18), 4465.
https://doi.org/10.3390/cancers15184465
